QUALITY OF LIFE IN PATIENTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AFTER 16 WEEKS OF GOLIMUMAB TREATMENT

被引:0
|
作者
Maksymowych, W. P. [1 ]
Curtis, S. [2 ]
Dougados, M. [3 ]
Bergman, G. [2 ]
Huyck, S. [2 ]
Tzontcheva, A. [2 ]
Sieper, J. [4 ]
机构
[1] Univ Alberta, Edmonton, AB, Canada
[2] Merck & Co Inc, Kenilworth, NJ USA
[3] Paris Descartes Univ, Paris, France
[4] Univ Clin Benjamin Franklin, Berlin, Germany
关键词
D O I
10.1136/annrheumdis-2015-eular.3046
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0757
引用
收藏
页码:1151 / 1152
页数:2
相关论文
共 50 条
  • [1] Quality of Life in Patients with Active Nonradiographic Axial Spondyloarthritis after 16 Weeks of Golimumab Treatment
    Maksymowych, Walter
    Curtis, Sean P.
    Dougados, Maxime
    Bergman, Gina
    Huyck, Susan
    Tzontcheva, Anjela
    Sieper, Joachim
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] Quality of Life in Patients with Active Non Radiographic Axial Spondyloarthritis After 16 Weeks of Golimumab Treatment
    Maksymowych, Walter
    Curtis, Sean
    Dougados, Maxime
    Bergman, Gina
    Huyck, Susan
    Tzontcheva, Anjela
    Sieper, Joachim
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1179 - 1180
  • [3] An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis
    Paccou, Julien
    Flipo, Rene-Marc
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2255 - 2261
  • [4] Baseline Demographic and Disease Characteristics Associated with Response to Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis
    Dougados, Maxime
    Bergman, Gina
    Maksymowych, Walter
    Curtis, Sean P.
    Huyck, Susan
    Tzontcheva, Anjela
    Sieper, Joachim
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [5] BASELINE DEMOGRAPHIC AND DISEASE CHARACTERISTICS ASSOCIATED WITH RESPONSE TO GOLIMUMAB IN PATIENTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
    Dougados, M.
    Bergman, G.
    Maksymowych, W. P.
    Curtis, S.
    Huyck, S.
    Tzontcheva, A.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 275 - 275
  • [6] Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials
    Toussirot, Eric
    Vauchy, Charline
    Binda, Delphine
    Michel, Fabrice
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2087 - 2094
  • [7] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 16-WEEK STUDY OF SUBCUTANEOUS GOLIMUMAB IN PATIENTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
    Sieper, J.
    van der Heijde, D.
    Dougados, M.
    Maksymowych, W. P.
    Boice, J. A.
    Bergman, G.
    Curtis, S.
    Tzontcheva, A.
    Huyck, S.
    Weng, H. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 283 - 283
  • [8] A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis.
    Sieper, J.
    van der Heijde, D.
    Dougados, M.
    Maksymowych, W.
    Boice, J.
    Bergman, G.
    Curtis, S.
    Tzontcheva, A.
    Huyck, S.
    Weng, H. H.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1283 - S1284
  • [9] Golimumab for the treatment of axial spondyloarthritis
    Palazzi, Carlo
    D'angelo, Salvatore
    Gilio, Michele
    Leccese, Pietro
    Padula, Angela
    Olivieri, Ignazio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (01) : 129 - 133
  • [10] Golimumab for the treatment of axial spondyloarthritis
    Gelfer, Gita
    Perry, Lisa
    Deodhar, Atul
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (01) : 9 - 18